ChemicalBook > Product Catalog >API >Specialty drugs >Dermatology drugs >guselkumab

guselkumab

Request For Quotation
guselkumab Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:Guselkumab
CAS:1350289-85-8
Purity:SDS-PAGE:95% SEC-HPLC:98.97% Package:1mg;663USD|5mg;2320USD|10mg;3120USD
Company Name: Aladdin Scientific
Tel:
Email: tp@aladdinsci.com
Products Intro: Product Name:Guselkumab (anti-IL-23)
CAS:1350289-85-8
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:$139.9/100μg;Bulk package Remarks:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Products Intro: Product Name:guselkumab
CAS:1350289-85-8
Remarks:Reach out to us for more information about custom solutions.
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 13636370518
Email: shyysw007@163.com
Products Intro: Product Name:Guselkumab (anti-IL-23)
CAS:1350289-85-8
Purity:ExactAb?, Validated, Carrier Free, Low Endotoxin, Azide Free Package:5mg Remarks:K10790
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com
Products Intro: Product Name:Guselkumab
CAS:1350289-85-8
Purity:95% Package:100ug;500ug;1mg

guselkumab manufacturers

  • Guselkumab
  • Guselkumab pictures
  • $179.00
  • 2026-07-27
  • CAS:1350289-85-8
  • Purity: 98.97% (SEC-HPLC)
  • Supply Ability: 10g
guselkumab Basic information
Product Name:guselkumab
Synonyms:guselkumab;Research Grade Guselkumab(DHJ63103);Guselkumab (anti-IL-23);CNTO 1959;Research Grade Guselkumab
CAS:1350289-85-8
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
guselkumab Structure
guselkumab Chemical Properties
storage temp. Store at -20°C
form Liquid
color Colorless to light yellow
Safety Information
MSDS Information
guselkumab Usage And Synthesis
UsesGuselkumab is a recombinant human IgG1 monoclonal antibody against the IL-23p19 subunit. Guselkumab binds to human and cynomolgus monkey IL-23 with Kd values of 3.3 and 1.9 pmol/L, respectively. Guselkumab inhibits production of cytokines lying downstream of the IL-23 signaling pathway and can be used for psoriatic arthritis research[1].
IC 50IL-23: .06 nM (IC50)
References[1] International non-proprietary name: guselkumab Procedure No. EMEA/H/C/004271/0000par-public-assessment-report_en.pdf
[2] Li Li, et al. IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis. Int Immunopharmacol DOI:10.1016/j.intimp.2020.107008
guselkumab Preparation Products And Raw materials
Tag:guselkumab(1350289-85-8) Related Product Information
Secukinumab Ixekizumab Briakinumab Brazikumab ibritumomab tiuxetan Ustekinumab Evolocumab Oleclumab Mirikizumab Brodalumab